Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease ; volume:270 ; number:11 ; day:22 ; month:7 ; year:2023 ; pages:5461-5474 ; date:11.2023
Journal of neurology ; 270, Heft 11 (22.7.2023), 5461-5474, 11.2023
- Urheber
-
Mizutani, Yasuaki
Ohdake, Reiko
Tatebe, Harutsugu
Higashi, Atsuhiro
Shima, Sayuri
Ueda, Akihiro
Ito, Mizuki
Tokuda, Takahiko
Watanabe, Hirohisa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-023-11875-z
- URN
-
urn:nbn:de:101:1-2024010414042021708948
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mizutani, Yasuaki
- Ohdake, Reiko
- Tatebe, Harutsugu
- Higashi, Atsuhiro
- Shima, Sayuri
- Ueda, Akihiro
- Ito, Mizuki
- Tokuda, Takahiko
- Watanabe, Hirohisa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Correction: Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Blood pressure variability and plasma Alzheimer’s disease biomarkers in older adults
Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Correction: Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Blood pressure variability and plasma Alzheimer’s disease biomarkers in older adults
Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Correction: Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Blood pressure variability and plasma Alzheimer’s disease biomarkers in older adults